|
PMD-026 Clinical Trials
2 actively recruiting trials across 2 locations
▲ +1 trial since May 2026
Pipeline
Phase 1: 1Phase 1/2: 1
Top Sponsors
- Washington University School of Medicine1
- Phoenix Molecular Designs1
Indications
- Cancer2
- Myelofibrosis1
- Metastatic Breast Cancer1
- Breast Cancer1
Gilbert, Arizona1 trial
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
Banner MD Anderson Cancer Center
Phase 1/2
St Louis, Missouri1 trial
Therapeutic RSK1 Targeting in Myelofibrosis
Washington University School of Medicine
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.